게시물 내용
[키움 미국전략/주식 김승혁/조민주] 🌏US Daily (2/10) (2/9 종가기준) - 주요 지수 수익률 S&P500 6,964.82 / 0.47% NASDAQ 종합 23,238.67 / 0.90% 다우산업 50,135.87 / 0.04% 러셀2000 2,689.05 / 0.70% 필라델피아 반도체 8,162.58 / 1.42% - 섹터별 수익률 High 3: 소프트웨어 (2.92%), 반도체 및 장비 (1.97%), 소재 (1.44%) Low 3: 보험 (-3.89%), 제약 (-1.03%), 호텔/레저 (-0.98%) - 세부 업종별 수익률 소프트웨어 2.92% 반도체 및 장비 1.97% 소재 1.44% 자동차 및 부품 1.03% 에너지 0.84% 엔터/미디어 0.82% 통신 0.65% 부동산 0.56% 자본재 0.51% 유틸리티 0.31% 상업 및 전문서비스 0.14% 은행 -0.10% 금융 -0.13% 하드웨어 -0.29% 운송 -0.41% 내구소비재/의류 -0.49% 헬스케어 -0.57% 유통 -0.68% 식료품 -0.78% 가정용품 -0.84% 음식료 및 담배 -0.93% 호텔/레저 -0.98% 제약 -1.03% - 종목별 수익률 High 3: APP (13.19%), ORCL (9.64%), GLW (7.56%) Low 3: WAT (-13.94%), WTW (-12.10%), AJG (-9.85%) - 주요 뉴스 ▶ Novo Nordisk sues Hims after $49 weight-loss pill sparks FDA backlash https://www.reuters.com/sustainability/boards-policy-regulation/novo-nordisk-shares-rise-hims-abandons-49-weight-loss-pill-2026-02-09/ ▶ Fed's Miran says weaker dollar not affecting monetary policy choices https://www.reuters.com/sustainability/boards-policy-regulation/feds-miran-says-weaker-dollar-not-affecting-monetary-policy-choices-2026-02-09/ ▶ Target steps up investment in store staffing, cuts about 500 other roles https://www.reuters.com/business/retail-consumer/target-steps-up-investment-store-staffing-cuts-about-500-other-roles-cnbc-2026-02-09/ ▶ US software stocks tumble sparks concerns that AI trade is reshaping markets https://www.reuters.com/business/media-telecom/us-software-stocks-tumble-sparks-concerns-that-ai-trade-is-reshaping-markets-2026-02-09/ ▶ Alphabet's debt raise fuels forecasts for record year in corporate bond sales https://www.reuters.com/business/retail-consumer/alphabets-debt-raise-fuels-forecasts-record-year-corporate-bond-sales-2026-02-09/ ▶ Waymo goes fully autonomous in Nashville https://www.reuters.com/business/autos-transportation/waymo-goes-fully-autonomous-nashville-2026-02-09/ ▶ Google sued by Autodesk over AI-powered movie-making software https://www.reuters.com/legal/litigation/google-sued-by-autodesk-over-ai-powered-movie-making-software-2026-02-09/ ▶ US FDA says Novo's obesity pill TV ad is false or misleading https://www.reuters.com/business/healthcare-pharmaceuticals/fda-says-novos-obesity-pill-tv-ad-is-false-or-misleading-2026-02-09/